Matches in Nanopublications for { ?s ?p "[The receptor tyrosine kinase MET is a prime target in clinical oncology due to its aberrant activation and involvement in the pathogenesis of a broad spectrum of malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP802759.RAXYRd8qecsyoN4drBQri7ix6WkI1qqgIcrgbfeqcnZTo130_assertion description "[The receptor tyrosine kinase MET is a prime target in clinical oncology due to its aberrant activation and involvement in the pathogenesis of a broad spectrum of malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802759.RAXYRd8qecsyoN4drBQri7ix6WkI1qqgIcrgbfeqcnZTo130_provenance.
- NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_assertion description "[The receptor tyrosine kinase MET is a prime target in clinical oncology due to its aberrant activation and involvement in the pathogenesis of a broad spectrum of malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945702.RAllKhnMc_vImXRqHAs9Z1NBNFuOWjq8DrZEhfcCDByi4130_provenance.
- NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_assertion description "[The receptor tyrosine kinase MET is a prime target in clinical oncology due to its aberrant activation and involvement in the pathogenesis of a broad spectrum of malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_provenance.